- Home
- KVHI vs SRZN Comparison
KVHI vs SRZN Comparison
Compare KVHI & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVHI
- SRZN
- Stock Information
- Founded
- KVHI 1978
- SRZN 2015
- Country
- KVHI United States
- SRZN United States
- Employees
- KVHI N/A
- SRZN N/A
- Industry
- KVHI Radio And Television Broadcasting And Communications Equipment
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- KVHI Technology
- SRZN Health Care
- Exchange
- KVHI Nasdaq
- SRZN Nasdaq
- Market Cap
- KVHI 119.2M
- SRZN 97.3M
- IPO Year
- KVHI 1996
- SRZN N/A
- Fundamental
- Price
- KVHI $6.14
- SRZN $11.53
- Analyst Decision
- KVHI
- SRZN Strong Buy
- Analyst Count
- KVHI 0
- SRZN 2
- Target Price
- KVHI N/A
- SRZN $38.50
- AVG Volume (30 Days)
- KVHI 31.7K
- SRZN 12.3K
- Earning Date
- KVHI 11-06-2025
- SRZN 11-05-2025
- Dividend Yield
- KVHI N/A
- SRZN N/A
- EPS Growth
- KVHI N/A
- SRZN N/A
- EPS
- KVHI N/A
- SRZN N/A
- Revenue
- KVHI $107,925,000.00
- SRZN $12,621,000.00
- Revenue This Year
- KVHI N/A
- SRZN N/A
- Revenue Next Year
- KVHI $14.15
- SRZN N/A
- P/E Ratio
- KVHI N/A
- SRZN N/A
- Revenue Growth
- KVHI N/A
- SRZN N/A
- 52 Week Low
- KVHI $4.35
- SRZN $5.90
- 52 Week High
- KVHI $6.37
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- KVHI 65.37
- SRZN 53.57
- Support Level
- KVHI $5.74
- SRZN $11.36
- Resistance Level
- KVHI $6.31
- SRZN $12.11
- Average True Range (ATR)
- KVHI 0.26
- SRZN 0.67
- MACD
- KVHI 0.03
- SRZN -0.14
- Stochastic Oscillator
- KVHI 77.45
- SRZN 30.08
About KVHI KVH Industries Inc.
KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).